C12N 2750/10033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2750/10033 (Use of viral protein as therapeutic agent other than vaccine) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 5
- Assignees
- 3
- Inventors
- 18
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 2 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Chimeric protein toxins for expression by therapeutic bacteria5 Aug 2025US 12,378,536 B1
- Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same8 Sep 2020US 10,767,185 B2Agricultural Technology Research Institute
- Chimeric protein toxins for expression by therapeutic bacteria9 Jun 2020US 10,676,723 B2
- Synthetic capsid proteins and uses thereof24 Jan 2017US 9,550,812 B2Ceva Sante Animale
- Novel recombinant porcine circovirus type 2 protein and use thereof16 Jan 2025US 2025/0018022 A1Innovac Corporation
- Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same14 Mar 2019US 2019/0078101 A1Agricultural Technology Research Institute
- Chimeric protein toxins for expression by therapeutic bacteria23 Feb 2017US 2017/0051260 A1
- Synthetic capsid proteins and uses thereof11 Dec 2014US 2014/0363459 A1Ceva Sante Animale
- Plasmid for expression of transgenes in plants27 Sep 2012US 2012/0245100 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.